998 related articles for article (PubMed ID: 26757967)
1. [Retrospective study of primary IgA nephropathy with crescent formation and/or rapidly progressive glomerulonephritis in children].
Wang D; Wang F; Ding J; Xiao H; Zhong X; Liu X
Zhonghua Er Ke Za Zhi; 2015 Sep; 53(9):670-5. PubMed ID: 26757967
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and pathological analysis of IgA nephropathy with acute kidney injury].
Chen MG; Ye XH; Liang HY; Yang Q
Zhonghua Er Ke Za Zhi; 2016 Aug; 54(8):610-3. PubMed ID: 27510875
[TBL] [Abstract][Full Text] [Related]
3. Clinical and pathological studies of IgA nephropathy presenting as a rapidly progressive form of glomerulonephritis.
Shimizu A; Takei T; Moriyama T; Itabashi M; Uchida K; Nitta K
Intern Med; 2013; 52(22):2489-94. PubMed ID: 24240786
[TBL] [Abstract][Full Text] [Related]
4. [Retrospective clinical features and renal pathological analysis of 15 children with anti-neutrophil cytoplasmic antibody-associated vasculitis].
Guan N; Yao Y; Yang JY; Xiao HJ; Ding J
Zhonghua Er Ke Za Zhi; 2013 Apr; 51(4):283-7. PubMed ID: 23927802
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic IgA nephropathy with diffuse crescent formation.
Tang Z; Wu Y; Wang QW; Yu YS; Hu WX; Yao XD; Chen HP; Liu ZH; Li LS
Am J Nephrol; 2002; 22(5-6):480-6. PubMed ID: 12381947
[TBL] [Abstract][Full Text] [Related]
6. Progression of membranous nephropathy to acute crescentic rapidly progressive glomerulonephritis and response to pulse methylprednisolone.
Koethe JD; Gerig JS; Glickman JL; Sturgill BC; Bolton WK
Am J Nephrol; 1986; 6(3):224-8. PubMed ID: 3740132
[TBL] [Abstract][Full Text] [Related]
7. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
Tang Z; Ji SM; Chen DR; Wen JQ; Chen JS; Liu ZH; Li LS
Ren Fail; 2008; 30(6):611-6. PubMed ID: 18661411
[TBL] [Abstract][Full Text] [Related]
8. Rapidly progressive IgA nephropathy.
Kobayashi N; Nishida M; Aoyama M; Yokoi K; Yahata T; Tatsujiro T; Sakata K; Shiraishi I; Itoi T; Hamaoka K
Indian J Pediatr; 2005 Mar; 72(3):257-60. PubMed ID: 15812125
[TBL] [Abstract][Full Text] [Related]
9. The effect of triple therapy on rapidly progressive type of Henoch-Schönlein nephritis.
Oner A; Tinaztepe K; Erdogan O
Pediatr Nephrol; 1995 Feb; 9(1):6-10. PubMed ID: 7742225
[TBL] [Abstract][Full Text] [Related]
10. Development of anti-glomerular basement membrane glomerulonephritis during the course of IgA nephropathy: a case report.
Kojima T; Hirose G; Komatsu S; Oshima T; Sugisaki K; Tomiyasu T; Yoshikawa N; Yamada M; Oda T
BMC Nephrol; 2019 Jan; 20(1):25. PubMed ID: 30683055
[TBL] [Abstract][Full Text] [Related]
11. Correlation between Pathological Findings and the Usefulness of Clinical Guidelines for the Treatment of ANCA-Positive RPGN: A Retrospective Analysis.
Yamada T; Kashiwagi T; Shimizu A; Tsuruoka S
J Nippon Med Sch; 2018; 85(5):259-264. PubMed ID: 30464142
[TBL] [Abstract][Full Text] [Related]
12. Effects of methylprednisolone and cyclophosphamide pulse therapy on renal infiltrating cells in patients with crescentic glomerulonephritis.
Tang Z; Zhou H; Yao X; Hu W; Leishi L
Chin Med J (Engl); 1997 Mar; 110(3):206-9. PubMed ID: 9594342
[TBL] [Abstract][Full Text] [Related]
13. Acute kidney injury in immunoglobulin A nephropathy: potential role of macroscopic hematuria and acute tubulointerstitial injury.
Kveder R; Lindic J; Ales A; Kovac D; Vizjak A; Ferluga D
Ther Apher Dial; 2009 Aug; 13(4):273-7. PubMed ID: 19695058
[TBL] [Abstract][Full Text] [Related]
14. Plasma exchange combined with immunosuppressive treatment in a child with rapidly progressive IgA nephropathy.
Fujinaga S; Ohtomo Y; Umino D; Mochizuki H; Murakami H; Shimizu T; Yamashiro Y; Kaneko K
Pediatr Nephrol; 2007 Jun; 22(6):899-902. PubMed ID: 17285293
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathological analysis of IgA nephropathy with crescentic formation in childhood].
Yao Y; Liu JC; Xiao HJ; Huang JP; Yang JY
Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):412-6. PubMed ID: 15265422
[TBL] [Abstract][Full Text] [Related]
16. High-frequency plasma exchange therapy for immunocompromised, type I crescentic glomerulonephritis complicated with IgA nephropathy: A case report and literature review.
Chen H; Jin J; Cheng MJ; He L; Zhou W; Guo L; Niu ZZ; Liang XN; Zhu RF; Bai Y; Xu JS
Medicine (Baltimore); 2023 Jan; 102(3):e32698. PubMed ID: 36701698
[TBL] [Abstract][Full Text] [Related]
17. Rapidly progressive glomerulonephritis due to anti-glomerular basement membrane disease accompanied by IgA nephropathy: An unusual association.
Annamalai I; Chandramohan G; Srinivasa Prasad ND; Fernando E; Sujith S
Saudi J Kidney Dis Transpl; 2017; 28(6):1404-1407. PubMed ID: 29265054
[TBL] [Abstract][Full Text] [Related]
18. Rapidly progressive IgA nephropathy.
Kobayashi N; Nishida M; Aoyama M; Yokoi K; Yahata T; Oka T; Sakata K; Shiraishi I; Itoi T; Hamaoka K
Indian J Pediatr; 2005 Mar; 72(3):257-260. PubMed ID: 28378174
[TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of tonsillectomy with modified high-dose intravenous methylprednisolone therapy in patients with IgA nephropathy].
Sugawara K; Takeda K; Nakai K; Takahashi N; Adachi T; Fukuda T; Miura S
Nihon Jinzo Gakkai Shi; 2008; 50(8):1017-23. PubMed ID: 19172803
[TBL] [Abstract][Full Text] [Related]
20. Rapidly progressive glomerulonephritis: analysis of prevalence and clinical course.
Andrassy K; Küster S; Waldherr R; Ritz E
Nephron; 1991; 59(2):206-12. PubMed ID: 1956482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
